Inventor · disambiguated record
James Tobin
Also filed as: TOBIN JAMES · TOBIN JAMES E · TOBIN JAMES F
7 granted patents·5 pending applications·126 citations·filing 1975–2018
86Inventor score
Files withGENETICS INST3ELC MAN LLC2GENETICS INST LLC2BOSTON SCIENT SCIMED INC1KLINGE CO CHEM PHARM FAB1
Top patents by PatentIndex Score
12 records- 0192US3992021ASki pole gripSCOTT USA·Filed 1975·Granted Nov 16, 1976·62 cites·10 claims
- 0278US7094402B2Antibodies to human interleukin-11 receptorGENETICS INST LLC·Filed 2001·Granted Aug 22, 2006·4 cites·12 claims
- 0369US6350855B1Human interleukin-11 receptorGENETICS INST·Filed 1997·Granted Feb 26, 2002·25 cites·13 claims
- 0465US6528281B1DNA encoding human interleukin-11 receptorGENETICS INST·Filed 1996·Granted Mar 4, 2003·19 cites·19 claims
- 0557US2007111939A1Human interleukin-11 receptorGENETICS INST LLC·Filed 2006·Application pending·0 cites
- 0655US2018228708A1Cleansing compositions and methodsELC MAN LLC·Filed 2018·Application pending·0 cites
- 0752US7901770B2Embolic compositionsBOSTON SCIENT SCIMED INC·Filed 2004·Granted Mar 8, 2011·4 cites·20 claims
- 0849US2017312198A1Cleansing Compositions And MethodsELC MAN LLC·Filed 2016·Application pending·0 cites
- 0943US6077534AProduction of pharmaceutical formulations for treatment of edema and venous disordersKLINGE CO CHEM PHARM FAB·Filed 1997·Granted Jun 20, 2000·10 cites·11 claims
- 1043US2010015072A1Topical Compositions Comprising IsonicotinamidePOLLA CHRISTOPHER·Filed 2009·Application pending·0 cites
- 1141US2006034831A1Combination therapy for diabetes, obesity and cardiovascular diseases using GDF-8 inhibitorsWYETH CORP·Filed 2005·Application pending·0 cites
- 1235US6274547B1Methods comprising the use of human interleukin-11 receptor proteinsGENETICS INST·Filed 1998·Granted Aug 14, 2001·2 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when James Tobin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →